4D Molecular Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FDMT research report →
Companywww.4dmoleculartherapeutics.com
4D Molecular Therapeutics, Inc. , a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology.
- CEO
- David H. Kirn
- IPO
- 2020
- Employees
- 227
- HQ
- EmeryVille, CA, US
Price Chart
Valuation
- Market Cap
- $449.72M
- P/E
- -3.64
- P/S
- 5.10
- P/B
- 1.30
- EV/EBITDA
- -2.22
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -12.45%
- Op Margin
- -203.47%
- Net Margin
- -182.34%
- ROE
- -36.83%
- ROIC
- -37.80%
Growth & Income
- Revenue
- $85.21M · 230194.59%
- Net Income
- $-140,109,000 · 12.90%
- EPS
- $-2.42 · 18.79%
- Op Income
- $-159,547,000
- FCF YoY
- 21.17%
Performance & Tape
- 52W High
- $12.34
- 52W Low
- $3.37
- 50D MA
- $9.47
- 200D MA
- $8.95
- Beta
- 2.76
- Avg Volume
- 745.82K
Get TickerSpark's AI analysis on FDMT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 25, 26 | Kirn David | other | 750,000 |
| Mar 25, 26 | Bizily Scott | other | 217,000 |
| Mar 25, 26 | Simms Christopher Paul | other | 219,000 |
| Mar 20, 26 | Gupta Ashoo | other | 865 |
| Mar 20, 26 | Gupta Ashoo | other | 221 |
| Mar 20, 26 | Gupta Ashoo | sell | 80 |
| Mar 20, 26 | Gupta Ashoo | sell | 310 |
| Mar 20, 26 | Gupta Ashoo | other | 865 |
| Mar 20, 26 | Gupta Ashoo | other | 221 |
| Jan 5, 26 | SBLENDORIO GLENN | other | 45,000 |
Our FDMT Coverage
We haven't published any research on FDMT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FDMT Report →